Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04273282 · ClinicalTrials.gov registry record · Phase 4
A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1%
A Phase 4 study, sponsored by Research Insight.
- Completed
- Registry status
- Phase 4
- Development phase
- 31
- Enrollment target
NCT04273282: Completed Phase 4 study, sponsored by Research Insight.
NCT04273282 is a Phase 4 study that has completed, run by Research Insight. The registered enrollment target is 31 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04273282, a Phase 4 study, has completed, sponsored by Research Insight.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 31 participants
- Enrollment target
Study Summary
This is a post-approval, open-label, randomized, self-controlled prospective clinical study to evaluate the safety and ocular efficacy of Dexycu in controlling postoperative ocular pain and inflammation associated with cataract surgery.
Primary Outcome
Patient preference for medication protocol between the two eyes, as reported based on the question, "Thinking about your overall experience taking medications in each eye after surgery, which eye did you prefer? Questionnaire
Interventions
- DRUG Prednisolone Acetate
- DRUG Dexycu intracameral dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2019-12-16 |
| Est. Completion | 2020-11-24 |
| Phase | Phase 4 |
What the finished NCT04273282 record still lists
NCT04273282 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Prednisolone Acetate is the first listed.
NCT04273282 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04273282 about?
NCT04273282 is a clinical study titled "A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1%". This is a post-approval, open-label, randomized, self-controlled prospective clinical study to evaluate the safety and ocular efficacy of Dexycu in controlling postoperative ocular pain and inflammation associated with cataract surgery.
What is the current status of trial NCT04273282?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 31 participants. The study started on 2019-12-16. Estimated completion is 2020-11-24.
What interventions are being tested in trial NCT04273282?
The interventions under investigation include: Prednisolone Acetate (DRUG), Dexycu intracameral dexamethasone (DRUG).
Who is sponsoring clinical trial NCT04273282?
This trial is sponsored by Research Insight, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04273282's enrollment target sits among peer trials
31 1544th of 2000 higher than 449 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI